Inventor · disambiguated record
Paul Carter
Also filed as: CARTER PAUL · CARTER PAUL J · CARTER PAUL JOHN · SUSSMAN DJANGO
55 granted patents·30 pending applications·18,914 citations·filing 1992–2024
99Inventor score
Top patents by PatentIndex Score
85 records- 0199US7695936B2Knobs and holes heteromeric polypeptidesGENENTECH INC·Filed 2006·Granted Apr 13, 2010·817 cites·73 claims
- 0299US7642228B2Method for making heteromultimeric polypeptidesGENENTECH INC·Filed 2001·Granted Jan 5, 2010·404 cites·40 claims
- 0399US6800738B1Method for making humanized antibodiesGENENTECH INC·Filed 2000·Granted Oct 5, 2004·274 cites·13 claims
- 0499US6719971B1Method for making humanized antibodiesGENENTECH INC·Filed 2000·Granted Apr 13, 2004·393 cites·5 claims
- 0599US6639055B1Method for making humanized antibodiesGENENTECH INC·Filed 2000·Granted Oct 28, 2003·523 cites·3 claims
- 0699US6407213B1Method for making humanized antibodiesGENENTECH INC·Filed 1992·Granted Jun 18, 2002·2.2k cites·82 claims
- 0799US6054297AHumanized antibodies and methods for making themGENENTECH INC·Filed 1995·Granted Apr 25, 2000·2.3k cites·30 claims
- 0899US5821337AImmunoglobulin variantsGENENTECH INC·Filed 1992·Granted Oct 13, 1998·4k cites·15 claims
- 0999US5821333AMethod for making heteromultimeric polypeptidesGENENTECH INC·Filed 1995·Granted Oct 13, 1998·681 cites·27 claims
- 1099US5807706AMethod for making heteromultimeric polypeptidesGENENTECH INC·Filed 1995·Granted Sep 15, 1998·587 cites·26 claims
- 1199US5731168AMethod for making heteromultimeric polypeptidesGENENTECH INC·Filed 1995·Granted Mar 24, 1998·2.6k cites·41 claims
- 1299US5648237AExpression of functional antibody fragmentsGENENTECH INC·Filed 1995·Granted Jul 15, 1997·1.5k cites·47 claims
- 1398US8679785B2Knobs and holes heteromeric polypeptidesCARTER PAUL J·Filed 2012·Granted Mar 25, 2014·67 cites·28 claims
- 1498US8455622B2Variant target binding agents and uses thereofCARTER PAUL·Filed 2007·Granted Jun 4, 2013·120 cites·21 claims
- 1598US8216805B2Knobs and holes heteromeric polypeptidesCARTER PAUL J·Filed 2010·Granted Jul 10, 2012·494 cites·36 claims
- 1698US7968687B2CD19 binding agents and uses thereofSEATTLE GENETICS INC·Filed 2008·Granted Jun 28, 2011·139 cites·14 claims
- 1798US7183076B2Method for making multispecific antibodies having heteromultimeric and common componentsGENENTECH INC·Filed 2002·Granted Feb 27, 2007·565 cites·38 claims
- 1897US9701752B2Humanized anti-CD70 binding agents and uses thereofSEATTLE GENETICS INC·Filed 2016·Granted Jul 11, 2017·30 cites·25 claims
- 1997US8075890B2Method for making humanized antibodiesCARTER PAUL J·Filed 2008·Granted Dec 13, 2011·39 cites·1 claims
- 2097US8067546B2Humanized anti-CD70 binding agents and uses thereofMCDONAGH CHARLOTTE·Filed 2006·Granted Nov 29, 2011·71 cites·25 claims
- 2197US7951917B1Method for making multispecific antibodies having heteromultimeric and common componentsGENENTECH INC·Filed 2000·Granted May 31, 2011·186 cites·12 claims
- 2297US7435797B2Anti-HER2 antibody variantsGENENTECH INC·Filed 2003·Granted Oct 14, 2008·79 cites·30 claims
- 2396US7288249B2Antibodies for cancer therapy and diagnosisGENENTECH INC·Filed 2003·Granted Oct 30, 2007·68 cites·6 claims
- 2495US9919061B2CD19 binding agents and uses thereofSEATTLE GENETICS INC·Filed 2015·Granted Mar 20, 2018·9 cites·16 claims
- 2595US9428585B2Humanized anti-CD70 binding agents and uses thereofSEATTLE GENETICS INC·Filed 2013·Granted Aug 30, 2016·26 cites·31 claims
- 2695US8562987B2Humanized anti-CD70 binding agents and uses thereofMCDONAGH CHARLOTTE·Filed 2011·Granted Oct 22, 2013·27 cites·24 claims
- 2795US7638606B2Antibodies that bind interleukin-4 receptorIMMUNEX CORP·Filed 2004·Granted Dec 29, 2009·60 cites·9 claims
- 2895US7018809B1Expression of functional antibody fragmentsGENENTECH INC·Filed 1992·Granted Mar 28, 2006·116 cites·11 claims
- 2994US8765412B2Method for making multispecific antibodies having heteromultimeric and common componentsARATHOON W ROBERT·Filed 2006·Granted Jul 1, 2014·43 cites·16 claims
- 3094US8642745B2Method for making multispecific antibodies having heteromultimeric and common componentsARATHOON W ROBERT·Filed 2006·Granted Feb 4, 2014·48 cites·11 claims
- 3194US7872113B2Nucleic acids encoding antibodies that bind interleukin-4 receptorIMMUNEX CORP·Filed 2009·Granted Jan 18, 2011·25 cites·12 claims
- 3293US8242252B2CD19 binding agents and uses thereofMCDONAGH CHARLOTTE·Filed 2011·Granted Aug 14, 2012·29 cites·19 claims
- 3393US7850966B2Method of treating breast cancer using anti-HER2 antibody variantsGENENTECH INC·Filed 2008·Granted Dec 14, 2010·45 cites·54 claims
- 3492US9409989B2Method for making multispecific antibodies having heteromultimeric and common componentsGENENTECH INC·Filed 2013·Granted Aug 9, 2016·13 cites·28 claims
- 3592US9073993B2CD19 binding agents and uses thereofMCDONAGH CHARLOTTE·Filed 2012·Granted Jul 7, 2015·10 cites·15 claims
- 3692US6342220B1Agonist antibodiesGENENTECH INC·Filed 1997·Granted Jan 29, 2002·90 cites·14 claims
- 3791US9061074B2Variant target binding agents and uses thereofSEATTLE GENETICS INC·Filed 2013·Granted Jun 23, 2015·13 cites·19 claims
- 3890US8257706B2CD30 binding agents and uses thereofMCDONAGH CHARLOTTE·Filed 2007·Granted Sep 4, 2012·20 cites·22 claims
- 3988US8840896B2Anti-HER2 antibody variantsLOWMAN HENRY B·Filed 2010·Granted Sep 23, 2014·21 cites·1 claims
- 4088US7524937B2WSX receptor agonist antibodiesGENENTECH INC·Filed 2006·Granted Apr 28, 2009·15 cites·18 claims
- 4187US11116840B2Multispecific antigen-binding proteinsGENENTECH INC·Filed 2017·Granted Sep 14, 2021·3 cites·16 claims
- 4286US5472855ASubstrate assisted catalysisGENENCOR INT·Filed 1994·Granted Dec 5, 1995·28 cites·14 claims
- 4386US5371190ASubstrate assisted catalysisGENENCOR INT·Filed 1993·Granted Dec 6, 1994·28 cites·15 claims
- 4486US2024190981A1Humanized Anti-CD70 Binding Agents and Uses ThereofSEAGEN INC·Filed 2023·Application pending·0 cites
- 4585US2025177523A1Multispecific antigen-binding proteinsGENENTECH INC·Filed 2024·Application pending·0 cites
- 4685US2024383984A1HUMANIZED AND AFFINITY MATURED ANTIBODIES TO FcRH5 AND METHODS OF USEGENENTECH INC·Filed 2024·Application pending·0 cites
- 4784US2025032610A1Multispecific antigen-binding proteinsGENENTECH INC·Filed 2024·Application pending·0 cites
- 4881US2024084031A1Variant target binding agents and uses thereofSEAGEN INC·Filed 2022·Application pending·0 cites
- 4980US5371008ASubstrate assisted catalysisGENENCOR INT·Filed 1993·Granted Dec 6, 1994·26 cites·12 claims
- 5079US10323094B2Humanized and affinity matured antibodies to FcRH5 and methods of useGENENTECH INC·Filed 2016·Granted Jun 18, 2019·2 cites·24 claims
Showing the top 50 of 85 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Paul Carter files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →